Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05675735 · ClinicalTrials.gov registry record · NA
Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder
A NA study of Problems Related to Social Environment, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 318
- Enrollment target
- 4
- Study locations
NCT05675735 is a NA study of Problems Related to Social Environment that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 318 participants. The trial reports 4 study locations across 2 states.
The verdict
NCT05675735, a NA study of Problems Related to Social Environment, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 318 participants
- Enrollment target
- 4
- Study locations
Study Summary
Using a stepped-wedge randomized controlled trial, the study will test whether a clinic-level multidimensional intervention conducted in 36 opioid treatment programs (OTPs) will improve clinical decision making, regulatory confusion, legal liability concerns, capacity for clinical practice change, and financial barriers to take- home dosing (THD) for methadone as compared to treatment as usual.
Conditions Studied
Interventions
- BEHAVIORAL Clinic-Level Multidimensional Intervention
Study Locations (4)
New York
- University at Buffalo - Buffalo
- NYU Langone Health - New York
- Weill Cornell Medical College - New York
Connecticut
- University of Connecticut - Storrs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 318 participants |
| Start Date | 2023-01-27 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05675735
The ClinicalTrials.gov registry entry for NCT05675735 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 318 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Problems Related to Social Environment appearing as the primary indexed condition, and to 1 intervention - of which Clinic-Level Multidimensional Intervention is the first listed.
NCT05675735 reports 4 study locations spanning 2 distinct geographic areas - top geographies include New York, Connecticut.
Frequently Asked Questions
What is clinical trial NCT05675735 about?
NCT05675735 is a clinical study titled "Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder". Using a stepped-wedge randomized controlled trial, the study will test whether a clinic-level multidimensional intervention conducted in 36 opioid treatment programs (OTPs) will improve clinical decision making, regulatory confusion, legal liability concerns, capacity for clinical practice change, a...
What is the current status of trial NCT05675735?
This trial is currently recruiting. It is a NA study. The enrollment target is 318 participants. The study started on 2023-01-27. Estimated completion is 2027-08-31.
What conditions does trial NCT05675735 study?
This clinical trial studies the following conditions: Problems Related to Social Environment.
What interventions are being tested in trial NCT05675735?
The interventions under investigation include: Clinic-Level Multidimensional Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05675735?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05675735 being conducted?
This trial has 4 study locations across Connecticut, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.